Adenylate cyclase 5 and KCa1.1 channel are required for EGFR up-regulation of PCNA in native contractile rat basilar artery smooth muscle

Journal of Physiology

Volumn 570, Issue 1, 2006, Pages 73-84

  Ivanov, Alexander ^a   Gerzanich, Volodymyr ^a   Ivanova, Svetlana ^a   DenHaese, Ryan ^a   Tsymbalyuk, Orest ^a   Simard, J Marc ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2',5' DIDEOXYADENOSINE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; ADENYLATE CYCLASE; ADENYLATE CYCLASE 5; ANGIOTENSIN II; ANTISENSE OLIGONUCLEOTIDE; CALCIUM ACTIVATED POTASSIUM CHANNEL; CYCLINE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; IBERIOTOXIN; KT 5720; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG; ANTISENSE OLIGODEOXYNUCLEOTIDE; CYCLIC AMP DEPENDENT PROTEIN KINASE; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASILAR ARTERY; CELL PROLIFERATION; CISTERNA MAGNA; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVATION; FEMALE; GENE ACTIVATION; HYPERPOLARIZATION; HYPERTENSION; NONHUMAN; PATCH CLAMP; PHENOTYPE; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; SMOOTH MUSCLE CONTRACTILITY; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; ADULT; ANIMAL TISSUE; CHANNEL GATING; IN VIVO STUDY; PATCH CLAMP TECHNIQUE; POTASSIUM CONDUCTANCE; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION; VASCULAR SMOOTH MUSCLE CELL;

ADENYLATE CYCLASE; ANIMALS; BASILAR ARTERY; CELL PROLIFERATION; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DIDEOXYADENOSINE; EPIDERMAL GROWTH FACTOR; FEMALE; ISOENZYMES; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MEMBRANE POTENTIALS; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OLIGONUCLEOTIDES, ANTISENSE; PATCH-CLAMP TECHNIQUES; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, WISTAR; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 33645924048     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2005.100883     Document Type: Article

References (42)

1. Berk BC, Brock TA, Webb RC, Taubman MB, Atkinson WJ, Gimbrone MA Jr & Alexander RW (1985). Epidermal growth factor, a vascular smooth muscle mitogen, induces rat aortic contraction. J Clin Invest 75, 1083-1086.
2. Bezzerides VJ, Ramsey IS, Kotecha S, Greka A & Clapham DE (2004). Rapid vesicular translocation and insertion of TRP channels. Nat Cell Biol 6, 709-720.
3. deBlois D, Drapeau G, Petitclerc E & Marceau F (1992). Synergism between the contractile effect of epidermal growth factor and that of des-Arg9-bradykinin or of alpha-thrombin in rabbit aortic rings. Br J Pharmacol 105, 959-967.
4. Chen Z, Nield HS, Sun H, Barbier A & Patel TB (1995). Expression of type V adenylyl cyclase is required for epidermal growth factor-mediated stimulation of cAMP accumulation. J Biol Chem 270, 27525-27530.
5. Cress AE (2000). Quantitation of phosphotyrosine signals in human prostate cell adhesion sites. Biotechniques 29, 776-781.
6. Dubois JM & Rouzaire-Dubois B (1993). Role of potassium channels in mitogenesis. Prog Biophys Mol Biol 59, 1-21.
7. Florian JA, Dorrance A, Webb RC & Watts SW (2001). Mineralocorticoids upregulate arterial contraction to epidermal growth factor. Am J Physiol Regul Integr Comp Physiol 281, R878-R886.
8. Florian JA & Watts SW (1999). Epidermal growth factor: A potent vasoconstrictor in experimental hypertension. Am J Physiol 276, H976-H983.
9. Gerzanich V, Ivanov A, Ivanova S, Yang JB, Zhou H, Dong Y & Simard JM (2003 a). Alternative splicing of cGMP-dependent protein kinase I in angiotensin-hypertension: Novel mechanism for nitrate tolerance in vascular smooth muscle. Circ Res 93, 805-812.
10. Gerzanich V, Ivanova S, van der Heijden MS, Zhou H & Simard JM (2003 b). Trans-cellular proliferating cell nuclear antigen gene activation in cerebral vascular smooth muscle by endothelial oxidative injury in vivo. Arterioscler Thromb Vasc Biol 23, 2048-2054.
11. 2+ channel activity in angiotensin-hypertension. Hypertension 41, 1124-1130.
12. Holland M, Langton PD, Standen NB & Boyle JP (1996). Effects of the BKCa channel activator, NS1619, on rat cerebral artery smooth muscle. Br J Pharmacol 117, 119-129.
13. Iwatsubo K, Minamisawa S, Tsunematsu T, Nakagome M, Toya Y, Tomlinson JE, Umemura S, Scarborough RM, Levy DE & Ishikawa Y (2004). Direct inhibition of type 5 adenylyl cyclase prevents myocardial apoptosis without functional deterioration. J Biol Chem 279, 40938-40945.
14. Kohler R, Wulff H, Eichler I, Kneifel M, Neumann D, Knorr A, Grgic I, Kampfe D, Si H, Wibawa J, Real R, Borner K, Brakemeier S, Orzechowski HD, Reusch HP, Paul M, Chandy KG & Hoyer J (2003). Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis. Circulation 108, 1119-1125.
15. Koyama H, Bornfeldt KE, Fukumoto S & Nishizawa Y (2001). Molecular pathways of cyclic nucleotide-induced inhibition of arterial smooth muscle cell proliferation. J Cell Physiol 186, 1-10.
16. Lazar LM & Blum M (1992). Regional distribution and developmental expression of epidermal growth factor and transforming growth factor-alpha mRNA in mouse brain by a quantitative nuclease protection assay. J Neurosci 12, 1688-1697.
17. Lee M, Simon AD, Stein CA & Rabbani LE (1999). Antisense strategies to inhibit restenosis. Antisense Nucl Acid Drug Dev 9, 487-792.
18. Levitzki A & Gazit A (1995). Tyrosine kinase inhibition: An approach to drug development. Science 267, 1782-1788.
19. Li S, Sims S, Jiao Y, Chow LH & Pickering JG (1999). Evidence from a novel human cell clone that adult vascular smooth muscle cells can convert reversibly between noncontractile and contractile phenotypes. Circ Res 85, 338-348.
20. Lovisolo D, Bonelli G, Baccino FM, Peres A, Alonzo F & Munaron L (1992). Two currents activated by epidermal growth factor in EGFR-T17 fibroblasts. Biochim Biophys Acta 1104, 73-82.
21. Lucchesi PA, Sabri A, Belmadani S & Matrougui K (2004). Involvement of metalloproteinases 2/9 in epidermal growth factor receptor transactivation in pressure-induced myogenic tone in mouse mesenteric resistance arteries. Circulation 110, 3587-3593.
22. + exchange by epidermal growth factor and vanadate in A431 cells is independent of phosphatidylinositol turnover and is inhibited by phorbol ester and diacylglycerol. J Biol Chem 261, 9321-9327.
23. Magni M, Meldolesi J & Pandiella A (1991). Ionic events induced by epidermal growth factor. Evidence that hyperpolarization and stimulated cation influx play a role in the stimulation of cell growth. J Biol Chem 266, 6329-6335.
24. Nair BG, Parikh B, Milligan G & Patel TB (1990). Gs alpha mediates epidermal growth factor-elicited stimulation of rat cardiac adenylate cyclase. J Biol Chem 265, 21317-32322.
25. Nair BG, Rashed HM & Patel TB (1993). Epidermal growth factor produces inotropic and chronotropic effects in rat hearts by increasing cyclic AMP accumulation. Growth Factors 8, 41-48.
26. 2+] at the mouth of a calcium channel. J Neurosci 17, 6961-6973.
27. Neylon CB (2002). Potassium channels and vascular proliferation. Vascul Pharmacol 38, 35-41.
28. + channel in vascular smooth muscle: Relationship between K(Ca) channel diversity and smooth muscle cell function. Circ Res 85, e33-e43.
29. Ono S, Date I, Nakajima M, Onoda K, Ogihara K, Shiota T, Asari S, Ninomiya Y, Yabuno N & Ohmoto T (1997). Three-dimensional analysis of vasospastic major cerebral arteries in rats with the corrosion cast technique. Stroke 28, 1631-1637.
30. Ostrom RS, Liu X, Head BP, Gregorian C, Seasholtz TM & Insel PA (2002). Localization of adenylyl cyclase isoforms and G protein-coupled receptors in vascular smooth muscle cells: Expression in caveolin-rich and noncaveolin domains. Mol Pharmacol 62, 983-992.
31. Pandiella A, Magni M, Lovisolo D & Meldolesi J (1989). The effect of epidermal growth factor on membrane potential. Rapid hyperpolarization followed by persistent fluctuations. J Biol Chem 264, 12914-12921.
32. Paunesku T, Mittal S, Protic M, Oryhon J, Korolev SV, Joachimiak A & Woloschak GE (2001). Proliferating cell nuclear antigen (PCNA): ringmaster of the genome. Int J Radiat Biol 77, 1007-1021.
33. Poppleton H, Sun H, Fulgham D, Bertics P & Patel TB (1996). Activation of Gsalpha by the epidermal growth factor receptor involves phosphorylation. J Biol Chem 271, 6947-6951.
34. + channel activity. J Membr Biol 196, 41-50.
35. Saltis J, Thomas AC, Agrotis A, Campbell JH, Campbell GR & Bobik A (1995). Expression of growth factor receptors in arterial smooth muscle cells. Dependency on cell phenotype and serum factors. Atherosclerosis 118, 77-87.
36. Thorin-Trescases N, Orlov SN, Taurin S, Dulin NO, Allen BG, deBlois D, Tremblay J, Pshezhetsky AV & Hamet P (2001). Antiproliferative effect of brief exposure to cholera toxin in vascular smooth muscle cells: Role of cAMP and protein kinase A. Can J Physiol Pharmacol 79, 471-480.
37. Tsien RY (1980). New calcium indicators and buffers with high selectivity against magnesium and protons: Design, synthesis, and properties of prototype structures. Biochemistry 19, 2396-2404. -2404.
38. + channel activity associated with human myeloblastic ML-1 cell proliferation. Am J Physiol 273, C1657-C1665.
39. Webb JG, Yates PW, Yang Q, Mukhin YV & Lanier SM (2001). Adenylyl cyclase isoforms and signal integration in models of vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 281, H1545-H1552.
40. Wonderlin WF & Strobl JS (1996). Potassium channels, proliferation and G1 progression. J Membr Biol 154, 91-107.
41. + -channel activity in growth factor-mediated extracellular signal-regulated kinase activation in human myeloblastic leukemia ML-1 cells. Blood 94, 139-145.
42. Zervas NT, Liszczak TM, Mayberg MR & Black PM (1982). Cerebrospinal fluid may nourish cerebral vessels through pathways in the adventitia that may be analogous to systemic vasa vasorum. J Neurosurg 56, 475-481.